Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide Monotherapy in First Relapsed Anaplastic Astrocytoma
NCT00783393Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2003
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temozolomide in anaplastic astrocytoma (AA), sponsored by Merck & Co.. Started May 2003; status: completed.
02
Drugs
temozolomide
03
Conditions
anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on NCT00783393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783393.